Peregrine Investment Management Inc. Reduces Holdings in Astera Labs

Summary

Peregrine Investment Management Inc. reduced its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 2.6% in Q2, now holding 146,040 shares, making it the fund’s second-largest position at 8.4% of its portfolio. Astera Labs reported strong Q2 earnings, with $0.44 EPS, exceeding estimates, and revenue of $191.93 million, up 149.5% year-over-year. Analysts have mixed ratings on the stock, with a consensus rating of ‘Moderate Buy’ and a target price of $152.94.Market Beat

Impact Analysis

So basically, Peregrine is trimming its position in Astera Labs despite the company posting impressive Q2 results with a 149.5% revenue increase and EPS beating estimates Market Beat. This move could be a classic case of portfolio rebalancing or risk management, especially since Astera Labs remains a significant part of their portfolio at 8.4% Market Beat. The interesting part isn’t the reduction itself, but the timing—right after strong earnings. It suggests Peregrine might be locking in gains or hedging against potential volatility, given the mixed analyst ratings and a ‘Moderate Buy’ consensus Market Beat. Market’s missing that this isn’t necessarily a bearish signal on Astera Labs but rather a strategic adjustment. I’d read this as a neutral to slightly positive signal for Astera Labs, as the fundamentals remain strong. Watching how other institutional investors react could provide further insights into market sentiment.